Pring Turner Capital Group Inc. Sells 70 Shares of The Clorox Company (NYSE:CLX)

Pring Turner Capital Group Inc. trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 0.3% during the 4th quarter, Holdings Channel reports. The fund owned 24,524 shares of the company’s stock after selling 70 shares during the period. Clorox comprises about 2.7% of Pring Turner Capital Group Inc.’s portfolio, making the stock its 15th largest position. Pring Turner Capital Group Inc.’s holdings in Clorox were worth $3,983,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Catalyst Capital Advisors LLC bought a new position in shares of Clorox during the third quarter valued at approximately $54,000. Los Angeles Capital Management LLC lifted its holdings in Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after buying an additional 10,149 shares during the period. Advisors Asset Management Inc. boosted its position in Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after acquiring an additional 9,037 shares in the last quarter. Natixis Advisors LLC boosted its position in Clorox by 8.3% during the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after acquiring an additional 4,839 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Clorox by 1.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after acquiring an additional 13,038 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

NYSE CLX opened at $154.52 on Tuesday. The company has a market cap of $19.03 billion, a price-to-earnings ratio of 42.22, a PEG ratio of 2.62 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock’s fifty day moving average price is $157.53 and its 200 day moving average price is $160.03. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the firm earned $2.16 EPS. As a group, equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Barclays upped their price objective on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Wells Fargo & Company increased their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, JPMorgan Chase & Co. raised their target price on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.